Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study

…, R Williams, G Vernet, M Chapman, L Levett… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …

[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

…, N Cortes, R Williams, MR Chapman, LJ Levett… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study

…, G Vernet, MR Chapman, LJ Levett… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

…, C Lambe, M Lappin, SA Lee, A Levett, L Levett… - The Lancet, 2020 - thelancet.com
To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …

Extraction-free COVID-19 (SARS-CoV-2) diagnosis by RT-PCR to increase capacity for national testing programmes during a pandemic

PR Grant, MA Turner, GY Shin, E Nastouli, LJ Levett - BioRxiv, 2020 - biorxiv.org
Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus disease
2019 (COVID-19), a respiratory tract infection. The standard molecular diagnostic test is …

Scalable and robust SARS-CoV-2 testing in an academic center

…, G Kassiotis, S Kirk, S Kjaer, A Levett, L Levett… - Nature …, 2020 - nature.com
To the Editor—The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
1–3 has led to a pandemic infecting more than seven million people worldwide in …

[HTML][HTML] Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

…, S Liggett, AH Beckett, MTG Holden, LJ Levett… - Journal of Hospital …, 2023 - Elsevier
Background The first epidemic wave of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
in Scotland resulted in high case numbers and mortality in care homes. In …

Use of real-time polymerase chain reaction for the detection of fetal aneuploidies

B Zimmermann, L Levett, W Holzgreve… - Clinical Applications of …, 2006 - Springer
With the advent of real-time polymerase chain reaction (PCR), it is now possible to measure
nucleic acid concentrations with an accuracy that was not possible only a few years ago. …

The QUTA activator and QUTR repressor proteins of Aspergillus nidulans interact to regulate transcription of the quinate utilization pathway genes

HK Lamb, GH Newton, LJ Levett, E Cairns… - …, 1996 - microbiologyresearch.org
Genetic evidence suggests that the activity of the native QUTA transcription activator protein
is negated by the action of the QUTR transcription repressor protein. When Aspergillus …

Incidence of placental mosaicism leading to discrepant results between QF‐PCR and karyotyping in 22,825 chorionic villus samples

E Holgado, S Liddle, T Ballard, L Levett - Prenatal diagnosis, 2011 - Wiley Online Library
Objective To review the frequency and analyse the origin of completely discrepant results
observed between QF‐PCR and karyotyping in chorionic villus samples (CVS) as a result of …